Abstract

ABSTRACTIn this study, we report the synthesis and biological evaluation of novel phthalimide based Schiff base derivatives as promising antioxidant and DNA-binding agents. The structural investigation of the synthesized compounds was determined by spectral and elemental analysis. In vitro DNA-binding studies of title compounds were carried out by UV–Vis, fluorescence, circular dichroism spectroscopic techniques, cyclic voltammetry, thermal denaturation studies, and hydrodynamic measurements to investigate their potential as DNA-binding agents. The DNA binding constant (Kb) of target compounds was obtained from absorption studies between 1.2 × 105 M−1 and 1.27 × 105 M−1, respectively, suggesting that the test compounds have shown good affinity toward calf-thymus DNA. The experimental results of DNA-binding studies reveal a non-intercalative mode of binding between DNA and the synthesized compounds, most probably groove binding. In addition, molecular docking techniques were performed to rationalize the observed binding affinities with the target DNA. Furthermore, antioxidant and free radical scavenging activities of the synthesized compounds were carried out to find out their pharmacological potential. The results indicate that the title compounds displayed good antioxidant activity against DPPH (IC50: 0.727 and 0.656 mg/mL) and H2O2 radicals (IC50: 1.072 and 0.911 mg/mL) comparable to standard ascorbic acid.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.